by Enli Liu, Melanie J. Percy, Christopher I

Slides:

Advertisements

Similar presentations

Lymphoma dissemination: the other face of lymphocyte homing by Steven T. Pals, David J. J. de Gorter, and Marcel Spaargaren Blood Volume 110(9):

Advertisements

Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome by Bart.

Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease- Causing Point Mutations Renee P. Stokowski, David R. Cox The American.

Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases by Porcia T. Bradford, Susan S. Devesa, William F. Anderson,

Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms by Pontus Lundberg, Axel Karow, Ronny Nienhold, Renate Looser,

Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.

The influence of high-altitude living on body iron

H/F-LV IS distribution in hCD34+ cells.

Do HSCs divide asymmetrically?

by Robert A. Kyle, Morie A. Gertz, Philip R. Greipp, Thomas E

by Robert F. Todd, Scott D. Gitlin, Linda J. Burns, and

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis by Samantha C. Gouw, H. Marijke.

Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene by A.

TCR-MHC-peptide(s): in vivo veritas

Higher Frequency of Glutathione S-Transferase Deletions in Black Children With Acute Lymphoblastic Leukemia by Chun-Lin Chen, Qing Liu, Ching-Hon Pui,

Immunosurveillance of Alglucerase Enzyme Therapy for Gaucher Patients: Induction of Humoral Tolerance in Seroconverted Patients After Repeat Administration.

Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients by Monia Ouederni, Quentin.

VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population by Daniel B. Bellissimo,

by David W. Bahler, John A. Miklos, and Steven H. Swerdlow

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

Rethinking bioactivity of FLT3 inhibitors

The V410I (G1228A) variant of the caspase-10 gene is a common polymorphism in the Danish population by Kirsten Grønbæk, Tine Dalby, Jesper Zeuthen, Elisabeth.

How I treat elderly patients with myeloma

An Interim Analysis Of a Phase 2, Single-Arm Study Of Platelet Responses and Remission Rates In Patients With Immune Thrombocytopenia (ITP) Receiving Romiplostim.

Nonmyeloablative conditioning for relapsed follicular lymphoma

by Martin de Boer, Egbert Bakker, Stefaan Van Lierde, and Dirk Roos

Pregnancy outcomes after maternal exposure to rituximab

Mutagenic potential of temozolomide in bone marrow cells in vivo

Fusion genes in cord blood

An Unusual Cause of Abdominal Pain in Sickle Cell Disease

Genetic sequence analysis of inherited bleeding diseases

Functional neutrophils from human ES cells

Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients by William J. Hogan,

Mutation Analysis of the Rearranged Immunoglobulin Heavy Chain Genes of Marginal Zone Cell Lymphomas Indicates an Origin From Different Marginal Zone B.

The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype.

Jacek Majewski The American Journal of Human Genetics

Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein.

Erythropoietin Receptor Mutations Associated With Familial Erythrocytosis Cause Hypersensitivity to Erythropoietin in the Heterozygous State by Stephanie.

JAK2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patients.

Red cell adenylate kinase deficiency: molecular study of 3 new mutations (118G>A, 190G>A, and GAC deletion) associated with hereditary nonspherocytic hemolytic.

Taking a leaf from the book of oral tolerance

by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle

Activation of multiple cryptic donor splice sites by the common congenital afibrinogenemia mutation, FGA IVS4 + 1 G→T by Catia Attanasio, Philippe de Moerloose,

How I treat refractory CLL

The factor V Leiden mutation: Spectrum of thrombotic events and laboratory evaluation Franklin A. Bontempo, MD, Andrea Cortese Hassett, PhD, Hawazin Faruki,

Line graph showing change in size over time relative to baseline CT

by Santosh L. Saraf, Xu Zhang, Tamir Kanias, James P. Lash, Robert E

Designer Lipids Advance Systemic siRNA Delivery

by Fumiko Chino, Arif H. Kamal, Junzo Chino, and Thomas W. LeBlanc

Mutations of von Hippel-Lindau Tumor-Suppressor Gene and Congenital Polycythemia Yves Pastore, Katerina Jedlickova, Yongli Guan, Enli Liu, James Fahner,

by Hannah L Bader, Tracy Pritchett, and Tien Hsu

Evolutionary History of the ADRB2 Gene in Humans

Distribution of average number of joint bleeds across factor activity level by age groups for patients with hemophilia B. In the boxplots, the central.

by H. Ddungu, M. Waiswa, R. Kruisselbrink, P. Kagoma, and M. Crowther

Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin by Sarah L. Reeves, Hannah K. Jary, Jennifer.

by Wendy Lim, Sara K. Vesely, and James N. George

Distribution of podocyte gene mutations in patients with genetic congenital nephrotic syndrome (CNS) and steroid–resistant nephrotic syndrome (SRNS). Distribution.

Amalia Martinez-Mir, Jianjun Liu, Derek Gordon, Madeline S

Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.

Survival based on V gene mutation status and CD38 expression among B-CLL patients who stratify to the Rai intermediate risk category. Survival based on.

Bigger, Stronger, Faster: Chimeric Antigen Receptor T Cells Are Olympic Killers by Paul J Neeson, Alexander James Davenport, Joseph A Trapani, Michael.

Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease by Joshua J. Field, Elaine Majerus, Victor.

Rituximab immunotherapy: it’s getting personal

Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S by Michael Makris, Michael Leach,

Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.

Schematic representations of pulmonary hypertension.

Sanjay Shete, Xiaojun Zhou, Christopher I. Amos

by Chatree Chai-Adisaksopha, Davide Matino, and Alfonso Iorio

by Victor A. Chow, Mazyar Shadman, and Ajay K. Gopal

Cold agglutinin disease

Presentation transcript:

The worldwide distribution of the VHL 598C>T mutation indicates a single founding event by Enli Liu, Melanie J. Percy, Christopher I. Amos, Yongli Guan, Sanjay Shete, David W. Stockton, Mary F. McMullin, Lydia A. Polyakova, Sonny O. Ang, Yves D. Pastore, Katerina Jedlickova, Terry R. J. Lappin, Victor Gordeuk, and Josef T. Prchal Blood Volume 103(5):1937-1940 March 1, 2004 ©2004 by American Society of Hematology

VHL haplotype system. VHL haplotype system. The shaded area is the VHL gene (14 543 bp). The asterisk (*) indicates that this mutation is associated with Chuvash polycythemia. Enli Liu et al. Blood 2004;103:1937-1940 ©2004 by American Society of Hematology